AstraZeneca's net income according to IFRS for the six months of 2021 amounted to $2.112 billion, an increase of 41.9% compared to $1.488 billion in the previous year. Revenue increased 23.1% to $15.54 billion compared to $12.629 billion a year earlier.
AstraZeneca's net income according to IFRS for the six months of 2021 amounted to $2.112 billion, an increase of 41.9% compared to $1.488 billion in the previous year. Revenue increased 23.1% to $15.54 billion compared to $12.629 billion a year earlier. 
astrazeneca.com
English (US) 